Assessment of iron deficiency in chronic hemodialysis patients: Investigation of cutoff values for reticulocyte hemoglobin content

Clinical and Experimental Nephrology

Volumn 7, Issue 1, 2003, Pages 52-57

  Mitsuiki, Koji ^a   Harada, Atsumi ^a   Miyata, Yasuji ^a  

^a MATSUYAMA RED CROSS HOSPITAL   (Japan)

Author keywords

Erythropoietin; Hemodialysis; Iron deficiency; Reticulocyte hemoglobin content

Indexed keywords

FERRITIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEMATOCRIT; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY; IRON THERAPY; MALE; RETICULOCYTE;

ADULT; AGED; DIETARY SUPPLEMENTS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRITINS; HEMATOCRIT; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; REFERENCE VALUES; RENAL DIALYSIS; RETICULOCYTES; RETROSPECTIVE STUDIES; TRANSFERRIN;

EID: 0037363941     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101570300007     Document Type: Article

References (28)

1. Macdougall IC. Poor response to erythropoietin: practical guideline on investigation and management. Nephrol Dial Transplant 1995;10:607-14.
2. Fishbane S, Frei GL, Maesaka J. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 1995;26:41-6.
3. Sunder-Plassmann G, Hörl WH. Importance of iron supply for erythropoietin therapy. Nephrol Dial Transplant 1995;10:2070-6.
4. Sepandj F, Jindal K, West M, Hirsch D. Economic appraisal of maintenance parenteral iron administration in treatment of anaemia in chronic haemodialysis patients. Nephrol Dial Transplant 1996;11:319-22.
5. Taylor JE, Peat N, Porter C, Morgan AG. Regular, low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients. Nephrol Dial Transplant 1996;11:1079-83.
6. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 1997;30:S192-S240.
7. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 1999;14:S1-S50.
8. Nissenson AR. Achieving target hematocrit in dialysis patients: new concepts in iron management. Am J Kidney Dis 1997;30:907-11.
9. Fishbane S, Galgano C, Langley RC, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997;52:217-22.
10. Mittman N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, et al. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 1997;30:912-22.
11. Cullen P, Söffker J, Höpfl M, Bremer C, Schlaghecken R, Mehrens T, et al. Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis. Nephrol Dial Transplant 1999;14:659-65.
12. Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int 2001;60:2406-11.
13. Mitsuiki K, Harada A, Miyata Y. Reduction of recombinant human erythropoietin maintenance dose by supplementation with a low-dose iron preparation, given intravenously. Clin Exp Nephrol 2001;5:228-33.
14. Lin J-L, Chang M-Y, Tan D-T, Leu M-L. Short-term small-dose intravenous iron trial to detect functional iron deficiency in dialysis patients. Am J Nephrol 2001;21:91-7.
15. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
16. Shatland BE, Winkel P, Bokeland H. Variation of serum iron concentration in young healthy men: within day and day to day changes. Clin Biochem 1976;9:26-31.
17. Rosenberg ME. Role of transferring measurement in monitoring iron status during recombinant human erythropoietin therapy. Dial Transplant 1992;21:81-90.
18. Ali M, Rigolosi R, Fayemi AO, Braun EV, Franscino J, Singer R. Failure of serum ferritin levels to pedict bone marrow iron content after intravenous iron-dextran therapy. Lancet 1982;I:652-5.
19. Macdougall IC, Cavill I, Hulme B, Bain B, McGregor E, McKay P, et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. BMJ 1992;304:225-6.
20. Beguin Y, Loo M, R'Zik S, Sautois B, Lejeune F, Rorive G, et al. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood 1993;82:2010-16.
21. Lowenstein LM. The mammalian reticulocyte. Int Rev Cytol 1959;8:135-74.
22. Groom AC, Song SH, Campling B. Clearance of red blood cells from the vascular bed of skeletal muscle with particular reference to reticulocytes. Microvasc Res 1994;6:51-62.
23. Mast AE, Blinder MA, Lu Q, Flax S, Dietzen DJ. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood 2002;99:1489-91.
24. Okano H, Tsuchiya K, Ando M, Teramura M, Nihei H. Concentration of reticulocyte hemoglobin in dialysis patients: a reliable tool for determination of iron deficiency and of iron supplement amount (abstract). J Jpn Soc Dial Ther 2001;34:1079-87.
25. Perry GS, Byers T, Yip R, Margen S. Iron nutrition does not account for the hemoglobin differences between blacks and whites. J Nutr 1992;122:1417-24.
26. Johnson-Spear MA, Yip R. Hemoglobin difference between black and white women with comparable iron status: justification for race-specific anemia criteria. Am J Clin Nutr 1994;60:117-21.
27. Milman N, Byg KE, Mulvad G, Pedersen HS, Bjerregaard P. Haemoglobin concentrations appear to be lower in indigenous Greenlanders than in Danes: assessment of haemoglobin in 234 Greenlanders and in 2804 Danes. Eur J Haematol 2001;67:23-9.
28. Besarab A, Amin N, Ahsan M, Vogel SE, Zazuwa G, Frinak S, et al. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol 2000;11:530-8.